NCT02451371View on ClinicalTrials.gov

Treatment of Refractory Auditory Verbal Hallucinations With tDCS in Schizophrenia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Schizophrenia
Interventions
DEVICE

tDCS

2mA direct current, 20 minutes per session, 2 sessions per day with at least 3hours interval between sessions, a total of 10 tDCS sessions

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02451371 - Treatment of Refractory Auditory Verbal Hallucinations With tDCS in Schizophrenia | Biotech Hunter | Biotech Hunter